A clinical trial to study the effect of Triphala churna with Madhu in Timir with special reference to Simple Myopia
Phase 2
- Conditions
- Health Condition 1: H521- Myopia
- Registration Number
- CTRI/2024/08/072268
- Lead Sponsor
- Dr Ashwini Raosaheb Borude
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
1. Patients of age group between 18-30 years with the clinical symptoms of prathama patalgata timira (simple myopia)
2. Patients having -0.25 D to -3.00 D Spherical power with normal Fundoscopic findings
Exclusion Criteria
Congenital myopia, Pathological myopia, Acquired or Secondary type of myopia that occurs due to some factors or diseases i.e. post traumatic, drug induced etc.
Patients who have myopia assosiated with other refractive errors such as Astigmatism.
Patients who are known case of hypertension,diabetes mellitus.
Patients who have active infectious diseases ie viral, fungal, bacterial conjunctivitis, trachoma, blephritis,
Patients below 18 years and above 30 years
Patient who have refractive index more than -3 D spherical
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Reduction in signs and symptoms of timir after taking Triphala churna with madhu orallyTimepoint: 30 days
- Secondary Outcome Measures
Name Time Method where the trial group stands in comparison with control groupTimepoint: 18 months